ADIPOQ and metabolic syndrome: Taken together from the aforementioned discussion it can be postulated that CME reduced HFD induced dyslipidemia and increased body weight gain through different pathways such as up-regulation of leptin, UCP1 and adiponectin expression and antioxidant activity.